An artist's view of drug-induced hallucinosis

Movement Disorders

Volumn 18, Issue 7, 2003, Pages 833-834

  Ebersbach, Georg ^a  

^a Fachkrankenhaus Bewegungsstorungen ^*  (Germany)

Author keywords

Amantadine; Hallucinations; Parkinson's disease

Indexed keywords

AMANTADINE SULFATE; ANTIPARKINSON AGENT; BENSERAZIDE PLUS LEVODOPA; CLOZAPINE; ENTACAPONE; PERGOLIDE;

ADULT; ANAMNESIS; ART; ARTICLE; CASE REPORT; CHOREA; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; VISUAL HALLUCINATION;

AMANTADINE; ANTIPARKINSON AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HALLUCINATIONS; HUMANS; MEDICINE IN ART; MIDDLE AGED; PARKINSON DISEASE; PERCEPTUAL DISTORTION; PHOTOGRAPHY;

EID: 0043092477     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10437     Document Type: Article

References (2)

1. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-745.
2. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001;70:727-733.